Nicole Tartaglia
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Klinefelter Syndrome | 19 | 2025 | 69 | 8.310 |
Why?
| | Trisomy | 22 | 2026 | 78 | 5.940 |
Why?
| | Sex Chromosome Aberrations | 21 | 2026 | 69 | 3.650 |
Why?
| | Sex Chromosomes | 18 | 2022 | 53 | 2.600 |
Why?
| | Sex Chromosome Disorders of Sex Development | 7 | 2024 | 17 | 2.530 |
Why?
| | Aneuploidy | 12 | 2022 | 90 | 2.360 |
Why?
| | Sex Chromosome Disorders | 9 | 2026 | 27 | 2.290 |
Why?
| | Autism Spectrum Disorder | 8 | 2025 | 410 | 2.280 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 10 | 2025 | 423 | 2.190 |
Why?
| | XYY Karyotype | 11 | 2025 | 24 | 1.760 |
Why?
| | Chromosomes, Human, X | 13 | 2024 | 76 | 1.700 |
Why?
| | Child Development | 3 | 2026 | 482 | 1.560 |
Why?
| | Developmental Disabilities | 6 | 2026 | 279 | 1.510 |
Why?
| | Fragile X Syndrome | 14 | 2022 | 119 | 1.490 |
Why?
| | Prenatal Diagnosis | 7 | 2023 | 196 | 1.290 |
Why?
| | Testosterone | 3 | 2025 | 412 | 1.060 |
Why?
| | Growth Charts | 1 | 2025 | 20 | 0.920 |
Why?
| | Body Height | 2 | 2025 | 199 | 0.920 |
Why?
| | Child | 47 | 2025 | 22600 | 0.890 |
Why?
| | Language Development | 1 | 2026 | 59 | 0.890 |
Why?
| | Child, Preschool | 34 | 2026 | 11790 | 0.870 |
Why?
| | Social Skills | 1 | 2025 | 30 | 0.870 |
Why?
| | Motor Skills | 1 | 2026 | 104 | 0.860 |
Why?
| | Psychotropic Drugs | 1 | 2025 | 77 | 0.850 |
Why?
| | Neurodevelopmental Disorders | 2 | 2025 | 223 | 0.850 |
Why?
| | Turner Syndrome | 2 | 2024 | 64 | 0.740 |
Why?
| | Phenotype | 13 | 2024 | 3147 | 0.740 |
Why?
| | Infant | 24 | 2026 | 10023 | 0.720 |
Why?
| | Adolescent | 31 | 2025 | 22409 | 0.660 |
Why?
| | Cognition Disorders | 5 | 2021 | 539 | 0.650 |
Why?
| | Chromosomes, Human, Y | 3 | 2009 | 37 | 0.640 |
Why?
| | Ovarian Reserve | 1 | 2020 | 17 | 0.630 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2020 | 40 | 0.620 |
Why?
| | Genetic Association Studies | 2 | 2021 | 369 | 0.580 |
Why?
| | Motor Skills Disorders | 1 | 2018 | 25 | 0.570 |
Why?
| | Male | 51 | 2026 | 72431 | 0.560 |
Why?
| | Humans | 72 | 2026 | 144667 | 0.550 |
Why?
| | Neuropsychological Tests | 12 | 2022 | 1134 | 0.540 |
Why?
| | Child Behavior | 5 | 2017 | 236 | 0.540 |
Why?
| | Child Development Disorders, Pervasive | 5 | 2012 | 62 | 0.540 |
Why?
| | Truth Disclosure | 2 | 2016 | 50 | 0.530 |
Why?
| | Chromosome Disorders | 2 | 2014 | 45 | 0.510 |
Why?
| | Genetic Testing | 4 | 2021 | 480 | 0.500 |
Why?
| | Students | 1 | 2022 | 657 | 0.480 |
Why?
| | Parents | 4 | 2023 | 1395 | 0.480 |
Why?
| | Adaptation, Physiological | 1 | 2020 | 567 | 0.470 |
Why?
| | Executive Function | 4 | 2022 | 460 | 0.450 |
Why?
| | Karyotyping | 4 | 2020 | 105 | 0.450 |
Why?
| | Young Adult | 16 | 2025 | 14122 | 0.430 |
Why?
| | Cognition | 8 | 2022 | 1263 | 0.430 |
Why?
| | Female | 34 | 2026 | 78304 | 0.430 |
Why?
| | Language Development Disorders | 3 | 2019 | 40 | 0.350 |
Why?
| | Adolescent Development | 1 | 2012 | 72 | 0.350 |
Why?
| | Autistic Disorder | 4 | 2020 | 211 | 0.340 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 1076 | 0.340 |
Why?
| | Parent-Child Relations | 1 | 2014 | 271 | 0.340 |
Why?
| | Mosaicism | 3 | 2024 | 73 | 0.330 |
Why?
| | Abnormalities, Multiple | 3 | 2012 | 197 | 0.320 |
Why?
| | Tremor | 2 | 2009 | 98 | 0.300 |
Why?
| | Hormone Replacement Therapy | 1 | 2010 | 107 | 0.300 |
Why?
| | Adult | 23 | 2025 | 40489 | 0.300 |
Why?
| | Obesity | 2 | 2020 | 3070 | 0.300 |
Why?
| | Emotions | 4 | 2023 | 578 | 0.290 |
Why?
| | Attention | 5 | 2022 | 458 | 0.270 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2172 | 0.270 |
Why?
| | Infant, Newborn | 4 | 2025 | 6399 | 0.270 |
Why?
| | Adolescent Behavior | 2 | 2012 | 497 | 0.260 |
Why?
| | Genetic Counseling | 3 | 2023 | 81 | 0.240 |
Why?
| | Cohort Studies | 4 | 2025 | 5957 | 0.230 |
Why?
| | Perceptual Disorders | 2 | 2019 | 24 | 0.220 |
Why?
| | Pregnancy | 4 | 2023 | 7122 | 0.220 |
Why?
| | Case-Control Studies | 4 | 2020 | 3603 | 0.220 |
Why?
| | DiGeorge Syndrome | 2 | 2019 | 34 | 0.220 |
Why?
| | Registries | 3 | 2024 | 2392 | 0.210 |
Why?
| | Space Perception | 2 | 2019 | 82 | 0.210 |
Why?
| | Double-Blind Method | 3 | 2025 | 2033 | 0.210 |
Why?
| | Child Behavior Disorders | 3 | 2016 | 118 | 0.210 |
Why?
| | Body Mass Index | 2 | 2025 | 2419 | 0.210 |
Why?
| | Reference Values | 1 | 2025 | 794 | 0.210 |
Why?
| | Comorbidity | 5 | 2022 | 1652 | 0.200 |
Why?
| | Y Chromosome | 1 | 2023 | 36 | 0.200 |
Why?
| | Behavior | 2 | 2019 | 90 | 0.200 |
Why?
| | Cell Adhesion Molecules, Neuronal | 2 | 2015 | 42 | 0.200 |
Why?
| | Behavioral Symptoms | 2 | 2022 | 41 | 0.200 |
Why?
| | Syndrome | 4 | 2020 | 379 | 0.190 |
Why?
| | Visual Perception | 2 | 2019 | 182 | 0.190 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2001 | 151 | 0.190 |
Why?
| | Puberty | 2 | 2016 | 135 | 0.190 |
Why?
| | Mitral Valve Prolapse | 1 | 2022 | 9 | 0.190 |
Why?
| | Social Behavior | 3 | 2022 | 287 | 0.180 |
Why?
| | Seizures | 4 | 2022 | 477 | 0.180 |
Why?
| | Social Change | 1 | 2022 | 15 | 0.180 |
Why?
| | Calcium-Binding Proteins | 2 | 2012 | 222 | 0.180 |
Why?
| | Theory of Mind | 1 | 2022 | 15 | 0.170 |
Why?
| | Body Composition | 1 | 2025 | 689 | 0.170 |
Why?
| | Body Weight | 1 | 2025 | 968 | 0.170 |
Why?
| | Anxiety | 3 | 2025 | 1122 | 0.170 |
Why?
| | Food, Formulated | 1 | 2020 | 16 | 0.160 |
Why?
| | Cyclic AMP | 1 | 2001 | 205 | 0.160 |
Why?
| | Prospective Studies | 2 | 2026 | 7994 | 0.160 |
Why?
| | Mental Disorders | 2 | 2017 | 1154 | 0.160 |
Why?
| | Cross-Sectional Studies | 6 | 2022 | 5870 | 0.160 |
Why?
| | Gonadotropins | 1 | 2020 | 39 | 0.160 |
Why?
| | Cannabidiol | 1 | 2022 | 139 | 0.160 |
Why?
| | Glutamates | 1 | 2020 | 66 | 0.160 |
Why?
| | Infant Formula | 1 | 2020 | 71 | 0.160 |
Why?
| | Anti-Mullerian Hormone | 1 | 2020 | 57 | 0.160 |
Why?
| | Educational Status | 1 | 2022 | 463 | 0.160 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 6041 | 0.160 |
Why?
| | Toilet Training | 1 | 2019 | 4 | 0.150 |
Why?
| | Waist Circumference | 1 | 2020 | 141 | 0.150 |
Why?
| | Intelligence | 1 | 2020 | 110 | 0.150 |
Why?
| | Mathematical Concepts | 1 | 2019 | 36 | 0.150 |
Why?
| | Time Perception | 1 | 2019 | 33 | 0.150 |
Why?
| | Irritable Mood | 1 | 2019 | 50 | 0.150 |
Why?
| | Counseling | 1 | 2022 | 405 | 0.150 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 70 | 0.150 |
Why?
| | Problem Behavior | 1 | 2020 | 101 | 0.140 |
Why?
| | Face | 1 | 2020 | 174 | 0.140 |
Why?
| | Auditory Perception | 1 | 2019 | 114 | 0.140 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 154 | 0.140 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 217 | 0.140 |
Why?
| | Hippocampus | 2 | 2001 | 966 | 0.140 |
Why?
| | Synapses | 2 | 2001 | 437 | 0.140 |
Why?
| | Aggression | 1 | 2019 | 178 | 0.130 |
Why?
| | Triglycerides | 1 | 2020 | 517 | 0.130 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 141 | 0.130 |
Why?
| | Memory, Short-Term | 1 | 2020 | 271 | 0.130 |
Why?
| | Prader-Willi Syndrome | 1 | 2017 | 31 | 0.130 |
Why?
| | Hypersensitivity | 1 | 2020 | 253 | 0.130 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 214 | 0.130 |
Why?
| | Oxandrolone | 1 | 2017 | 6 | 0.130 |
Why?
| | Eosinophilic Esophagitis | 1 | 2021 | 331 | 0.130 |
Why?
| | Depression | 2 | 2025 | 1561 | 0.130 |
Why?
| | Disability Evaluation | 1 | 2018 | 310 | 0.130 |
Why?
| | Facies | 1 | 2016 | 22 | 0.120 |
Why?
| | Estradiol | 1 | 2020 | 507 | 0.120 |
Why?
| | Speech Disorders | 1 | 2016 | 29 | 0.120 |
Why?
| | X Chromosome Inactivation | 1 | 2016 | 25 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 581 | 0.120 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5414 | 0.120 |
Why?
| | Testis | 1 | 2016 | 162 | 0.110 |
Why?
| | Transcription Factors | 1 | 2023 | 1726 | 0.110 |
Why?
| | Androgens | 1 | 2017 | 178 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2922 | 0.110 |
Why?
| | Physical Examination | 1 | 2016 | 240 | 0.110 |
Why?
| | Nerve Tissue Proteins | 3 | 2012 | 590 | 0.110 |
Why?
| | Down Syndrome | 2 | 2013 | 522 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 293 | 0.100 |
Why?
| | Muscle Strength | 1 | 2017 | 330 | 0.100 |
Why?
| | Polymorphism, Genetic | 1 | 2016 | 613 | 0.100 |
Why?
| | Trisomy 13 Syndrome | 1 | 2013 | 2 | 0.100 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2013 | 15 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2350 | 0.090 |
Why?
| | Tetrasomy | 1 | 2012 | 2 | 0.090 |
Why?
| | Self Concept | 1 | 2014 | 256 | 0.090 |
Why?
| | Wechsler Scales | 1 | 2012 | 59 | 0.090 |
Why?
| | Retrospective Studies | 4 | 2025 | 17149 | 0.090 |
Why?
| | Trinucleotide Repeat Expansion | 2 | 2008 | 44 | 0.080 |
Why?
| | Exons | 1 | 2012 | 362 | 0.080 |
Why?
| | Prevalence | 3 | 2024 | 2839 | 0.080 |
Why?
| | Gene Deletion | 1 | 2012 | 392 | 0.080 |
Why?
| | Hypogonadism | 1 | 2011 | 90 | 0.080 |
Why?
| | Intellectual Disability | 1 | 2012 | 174 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2012 | 539 | 0.080 |
Why?
| | Data Collection | 1 | 2013 | 635 | 0.080 |
Why?
| | Nonlinear Dynamics | 1 | 2010 | 96 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1766 | 0.070 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2008 | 133 | 0.070 |
Why?
| | Language Disorders | 1 | 2009 | 29 | 0.070 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2008 | 46 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1406 | 0.070 |
Why?
| | Chromosome Deletion | 1 | 2008 | 124 | 0.060 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2008 | 82 | 0.060 |
Why?
| | Genotype | 1 | 2012 | 1847 | 0.060 |
Why?
| | Psychomotor Performance | 1 | 2009 | 328 | 0.060 |
Why?
| | Risk Factors | 1 | 2020 | 10796 | 0.060 |
Why?
| | Middle Aged | 6 | 2019 | 35971 | 0.060 |
Why?
| | Vagus Nerve | 2 | 1997 | 92 | 0.060 |
Why?
| | United States | 1 | 2022 | 16018 | 0.050 |
Why?
| | Interleukin-1 | 3 | 1997 | 961 | 0.050 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2003 | 50 | 0.050 |
Why?
| | Gene Duplication | 1 | 2003 | 67 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2573 | 0.050 |
Why?
| | Muscle Hypotonia | 2 | 2013 | 33 | 0.050 |
Why?
| | Time Factors | 2 | 2013 | 7140 | 0.050 |
Why?
| | Gels | 1 | 2022 | 85 | 0.050 |
Why?
| | Mental Status and Dementia Tests | 1 | 2022 | 26 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 3 | 2010 | 323 | 0.040 |
Why?
| | Abnormal Karyotype | 1 | 2021 | 2 | 0.040 |
Why?
| | Synaptotagmins | 1 | 2001 | 22 | 0.040 |
Why?
| | Vocabulary | 1 | 2021 | 35 | 0.040 |
Why?
| | Synaptic Vesicles | 1 | 2001 | 40 | 0.040 |
Why?
| | Rats | 5 | 2001 | 5570 | 0.040 |
Why?
| | Mutation | 2 | 2009 | 4081 | 0.040 |
Why?
| | Risperidone | 1 | 2019 | 29 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1046 | 0.040 |
Why?
| | Long-Term Potentiation | 1 | 2001 | 199 | 0.040 |
Why?
| | Language | 1 | 2022 | 323 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 1476 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 496 | 0.040 |
Why?
| | Adaptation, Psychological | 1 | 2023 | 718 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 664 | 0.030 |
Why?
| | Antidepressive Agents | 1 | 2019 | 248 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1501 | 0.030 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 306 | 0.030 |
Why?
| | Glucose Intolerance | 1 | 2017 | 142 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 905 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 211 | 0.030 |
Why?
| | Communication | 1 | 2022 | 972 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2942 | 0.030 |
Why?
| | Animals | 7 | 2017 | 37948 | 0.030 |
Why?
| | Metformin | 1 | 2017 | 320 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2017 | 399 | 0.020 |
Why?
| | Hand Deformities | 1 | 2013 | 3 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2104 | 0.020 |
Why?
| | Megalencephaly | 1 | 2013 | 19 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2021 | 1176 | 0.020 |
Why?
| | Fever | 1 | 1995 | 313 | 0.020 |
Why?
| | Research | 1 | 2016 | 431 | 0.020 |
Why?
| | Taste | 1 | 1995 | 240 | 0.020 |
Why?
| | Brain | 2 | 1995 | 2934 | 0.020 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2012 | 38 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2012 | 116 | 0.020 |
Why?
| | DNA Copy Number Variations | 1 | 2012 | 184 | 0.020 |
Why?
| | Social Class | 1 | 2013 | 265 | 0.020 |
Why?
| | Introns | 1 | 2012 | 255 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 4 | 1999 | 2521 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2012 | 396 | 0.020 |
Why?
| | Short Stature Homeobox Protein | 1 | 2010 | 1 | 0.020 |
Why?
| | Esophagitis | 1 | 2010 | 67 | 0.020 |
Why?
| | Gene Dosage | 1 | 2010 | 148 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2017 | 11735 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2009 | 107 | 0.020 |
Why?
| | Trinucleotide Repeats | 1 | 2008 | 31 | 0.020 |
Why?
| | DNA Repeat Expansion | 1 | 2008 | 12 | 0.020 |
Why?
| | Ataxia | 1 | 2008 | 69 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2008 | 44 | 0.020 |
Why?
| | Fibromyalgia | 1 | 2008 | 52 | 0.020 |
Why?
| | Chromosome Aberrations | 1 | 2008 | 164 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 305 | 0.020 |
Why?
| | Physicians | 1 | 2016 | 949 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1047 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2010 | 300 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2009 | 313 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2010 | 523 | 0.010 |
Why?
| | Heterozygote | 1 | 2007 | 313 | 0.010 |
Why?
| | Signal Transduction | 1 | 1999 | 5185 | 0.010 |
Why?
| | Vagotomy | 2 | 1995 | 33 | 0.010 |
Why?
| | Quality of Life | 1 | 2016 | 3183 | 0.010 |
Why?
| | Stereotypic Movement Disorder | 1 | 2003 | 10 | 0.010 |
Why?
| | Pedigree | 1 | 2003 | 515 | 0.010 |
Why?
| | Phospholipase C gamma | 1 | 1999 | 28 | 0.010 |
Why?
| | Hypertension | 1 | 2008 | 1262 | 0.010 |
Why?
| | Type C Phospholipases | 1 | 1999 | 69 | 0.010 |
Why?
| | Electrophysiology | 1 | 1999 | 218 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 165 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 297 | 0.010 |
Why?
| | Mass Screening | 1 | 2007 | 1348 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 380 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1997 | 78 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1999 | 890 | 0.010 |
Why?
| | Saccharin | 1 | 1995 | 9 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 2019 | 0.010 |
Why?
| | Stress, Physiological | 1 | 1995 | 451 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1995 | 1207 | 0.000 |
Why?
| | Aged | 1 | 2008 | 25955 | 0.000 |
Why?
| | Cytokines | 1 | 1995 | 2045 | 0.000 |
Why?
|
|
Tartaglia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|